HLB Therapeutics Co Ltd
KOSDAQ:115450
Shareholder Yield
Current shareholder yield for HLB Therapeutics Co Ltd is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
HLB Therapeutics Co Ltd
| Average Annual Return | 29.46% |
| Standard Deviation of Annual Returns | 103.43% |
| Max Drawdown | -84% |
| Market Capitalization | 249.4B KRW |
| Shares Outstanding | 84 380 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
HLB Therapeutics Co Ltd's latest stock split occurred on Mar 12, 2026
The company executed a 21-for-20 stock split, meaning that for every 20 shares held, investors received 21 new shares.
Before the split, HLB Therapeutics Co Ltd traded at 3070.0002 per share. Afterward, the share price was about 3025.
The adjusted shares began trading on Mar 12, 2026. This was HLB Therapeutics Co Ltd's 6th stock split, following the previous one in Jan 14, 2025.
